about
The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?The renin-angiotensin system in essential hypertension: associations with cardiovascular risk.Pharmacologically induced thoracic and abdominal aortic aneurysms in mice.Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin.Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient miceRenin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk management.Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol dietDifferential roles of endothelin-1 in angiotensin II-induced atherosclerosis and aortic aneurysms in apolipoprotein E-null mice.Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice.Microarray gene expression profiling reveals antioxidant-like effects of angiotensin II inhibition in atherosclerosis.Elastase-induced intracranial aneurysms in hypertensive mice.Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.Anti-atherosclerotic efficacy of olmesartan.Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages.Atorvastatin completely inhibits VEGF-induced ACE upregulation in human endothelial cells.Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.
P2860
Q24317652-76D89DF3-93B9-40C7-9D0E-19EEA9E547F1Q33713602-4E12C783-F3E8-4B53-B805-998A91FE632CQ33811613-284FD7E3-9721-4F15-85E4-1BAFDCC806BDQ34163164-2F97F482-C851-49D5-BCE2-2F1684767D89Q34433103-F71374BE-F8C8-43D6-98A5-126657625070Q34849588-3E3D9DF6-97EE-4290-958B-18E23C2EDC54Q35041595-14A05307-C37C-47ED-A15B-8FBCDF63787FQ35168157-D1C705AA-9705-430E-AADE-8D9D8FE294EFQ35746906-22AF992A-2E14-4BE4-81C6-A99A5DF4DDFEQ36938178-52950921-0FCC-438B-8406-01DD4EB11339Q42948500-C0022FBA-44EB-40D1-9EB4-381D9C8E2CAAQ43710362-BF906D18-497F-40C0-B324-D168BAE78A04Q43967976-C315C4B4-7E04-49A4-B2D6-4EF23B0C89F7Q43976703-2041431D-0EB2-4C39-AAB8-6D61D33400DBQ44712590-36F5C5F0-4F2A-4320-87D8-35BA119E9214Q46599371-120EDAD8-EFC7-4F14-AD07-3588647A1908
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Angiotensin, LDL peroxidation and atherosclerosis.
@en
Angiotensin, LDL peroxidation and atherosclerosis.
@nl
type
label
Angiotensin, LDL peroxidation and atherosclerosis.
@en
Angiotensin, LDL peroxidation and atherosclerosis.
@nl
prefLabel
Angiotensin, LDL peroxidation and atherosclerosis.
@en
Angiotensin, LDL peroxidation and atherosclerosis.
@nl
P1433
P1476
Angiotensin, LDL peroxidation and atherosclerosis.
@en
P2093
P356
10.1016/S0024-3205(98)00014-9
P407
P577
1998-01-01T00:00:00Z